input_term,has_context,match_1,score_1,match_2,score_2,match_3,score_3,match_4,score_4,match_5,score_5
25-30% DUCTAL COMPONENT,Yes,Prostate Ductal Adenocarcinoma,30.0,Pancreatic Ductal Adenocarcinoma,23.33,Ductal Eccrine Adenocarcinoma,23.33,Prostate Adenocarcinoma,20.0,Adenocarcinoma,20.0
AB,Yes,Unresectable Carcinoma,60.0,Resectable Carcinoma,60.0,Unresectable Vaginal Carcinoma,56.67,Unresectable Vulvar Carcinoma,56.67,Labia Majora Carcinoma,56.67
ACANTHOLYTIC,Yes,Skin Acantholytic Squamous Cell Carcinoma,91.0,Laryngeal Acantholytic Squamous Cell Carcinoma,87.0,"Breast Squamous Cell Carcinoma, Acantholytic Variant",83.33,Acantholytic Acanthoma,75.0,Skin Carcinoma,35.0
ACC,Yes,Tobacco-Related Carcinoma,66.67,Tobacco Chewing-Related Carcinoma,65.0,Benign Accessory Urethral Gland Neoplasm,50.0,Accessory Urethral Gland Adenocarcinoma,50.0,Malignant Accessory Urethral Gland Neoplasm,50.0
"ACUTE MYELOGENOUS LEUKEMIA AML, M3 PROMYELOCYTIC",No,Leukemia,61.0,Typical Acute Promyelocytic Leukemia,33.0,Microgranular Acute Promyelocytic Leukemia,33.0,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,27.86,Aleukemic Acute Lymphoblastic Leukemia Cutis,27.0
"ACUTE MYELOGENOUS LEUKEMIA AML, M5 EOSINOPHILIC/MONOCYTIC",No,Leukemia,60.0,Refractory Acute Monoblastic and Monocytic Leukemia,30.0,Recurrent Acute Monoblastic and Monocytic Leukemia,30.0,Recurrent Acute Monocytic Leukemia,30.0,Childhood Acute Monoblastic and Monocytic Leukemia,30.0
ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA RELATED CHANGES,No,Acute Myeloid Leukemia,70.0,Myeloid Leukemia,65.0,Leukemia,60.0,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",40.0,"Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related",40.0
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T15;17Q22;Q12;  PML-RARA,No,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,32.14,Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,30.0,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,30.0,Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,30.0,Typical Acute Promyelocytic Leukemia,23.57
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T15;17Q22;Q12; PML-RARA,No,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,32.14,Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,30.0,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,30.0,Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,30.0,Typical Acute Promyelocytic Leukemia,23.57
ACYC,Yes,Salivary Gland Adenoid Cystic Carcinoma,70.0,Minor Salivary Gland Adenoid Cystic Carcinoma,66.67,Major Salivary Gland Adenoid Cystic Carcinoma,66.67,Bartholin Gland Adenoid Cystic Carcinoma,66.0,Parotid Gland Adenoid Cystic Carcinoma,66.0
ADCA ACINAR WITH MUCIN PRODUCTION,No,Recurrent Prostate Acinar Adenocarcinoma,37.5,Prostate Acinar Adenocarcinoma,37.5,Prostate Acinar Microcystic Adenocarcinoma,37.5,Prostate Acinar Pseudohyperplastic Adenocarcinoma,37.5,Prostate Acinar Oncocytic Adenocarcinoma,37.5
ADENOCARINOMA,Yes,Adenocarcinoma,35.0,Vaginal Adenocarcinoma,25.0,Mesonephric Adenocarcinoma,25.0,Vulvar Adenocarcinoma,25.0,Ovarian Adenocarcinoma,25.0
AMELANOTIC NODULAR,Yes,Nodular Melanoma,35.0,Amelanotic Melanoma,35.0,Cutaneous Nodular Melanoma,30.0,Amelanotic Cutaneous Melanoma,30.0,"Ganglioneuroblastoma, Nodular",25.0
AML WITH BIALLELIC MUTATIONS OF CEBPA,Yes,Leukemia,35.0,Acute Myeloid Leukemia with Biallelic CEBPA Mutation,35.0,Acute Myeloid Leukemia with CEBPA Mutation,29.0,Acute Myeloid Leukemia with Germline CEBPA Mutation,26.67,Acute Myeloid Leukemia with Monoallelic CEBPA Mutation,26.67
"AML WITH INV3Q21.3;Q26.2 OR T3;3Q21.3;Q26.2; GATA2, MECOM",No,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",27.86,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",26.25,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",26.25,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",23.57,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,23.57
"AML WITH INV3Q21.3Q26.2 OR T3;3Q21.3;Q26.2; GATA2, MECOM",No,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",27.86,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",26.25,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",26.25,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",23.57,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,23.57
AML WITH INV3Q21;Q26.2 OR T3;3Q21;Q26.2; RPN1-EVI1,No,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",19.29,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,19.29,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,19.29,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",19.29,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",18.75
AML WITH INV3Q21Q26.2 OR T3;3Q21;Q26.2; RPN1-EVI1,No,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",19.29,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,19.29,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,19.29,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",19.29,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",18.75
AML WITH MUTATED CEBPA,Yes,Leukemia,35.0,Acute Myeloid Leukemia with Biallelic CEBPA Mutation,30.0,Acute Myeloid Leukemia with CEBPA Mutation,29.0,Acute Myeloid Leukemia with Germline CEBPA Mutation,26.67,Acute Myeloid Leukemia with Monoallelic CEBPA Mutation,26.67
AML WITH MUTATED NPM1,Yes,Leukemia,35.0,Acute Myeloid Leukemia with Mutated TP53,29.0,Acute Myeloid Leukemia with NPM1-MLF1,29.0,Acute Myeloid Leukemia with NPM1 Mutation,29.0,B Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R),26.67
AML WITH MUTATED RUNX1,No,Acute Myeloid Leukemia with Mutated TP53,21.0,Acute Myeloid Leukemia with RUNX1 Mutation,21.0,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,20.0,B Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R),20.0,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,19.29
AML WITH MYELODYSPLASIA-RELATED CHANGES,Yes,"Acute Myeloid Leukemia, Myelodysplasia-Related",39.0,Radiation-Related Leukemia,35.83,Therapy-Related Leukemia,35.83,Chemotherapy-Related Leukemia,35.83,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",35.0
AML WITH T6:9P23:Q34.1; DEK-NUP214,No,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,27.86,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,19.29,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,19.29,Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,18.75,Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,18.75
AML WITH T6;9P23;Q34.1;DEK-NUP214,No,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,27.86,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,19.29,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,19.29,Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,18.75,Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,18.75
AML WITH T6;9P23;Q34; DEK-NUP214,No,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,27.86,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,19.29,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,19.29,Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,18.75,Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,18.75
AML WITH T8;21Q22;Q22.1; RUNX1-RUNX1T1,No,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,30.0,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,27.86,Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,27.86,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,23.57,B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1,23.57
AML WITH T8;21Q22;Q22.1;RUNX1-RUNX1T1,No,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,30.0,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,27.86,Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,27.86,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,23.57,B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1,23.57
AML WITH T8;21Q22;Q22; RUNX1-RUNX1T1,No,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,30.0,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,27.86,Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,27.86,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,23.57,B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1,23.57
AML WITH T9;11P22;Q23;  MLLT3-MLL,No,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,23.57,Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,22.5,Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,22.5,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,22.5,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,19.29
AML WITH T9;11P22;Q23; MLLT3-MLL,No,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,23.57,Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,22.5,Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,22.5,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,22.5,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,19.29
"AML, NOS",Yes,Leukemia,35.0,Testicular Leukemia,25.0,Meningeal Leukemia,25.0,Leukemia Cutis,25.0,Refractory Leukemia,25.0
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,No,Lymphoma,65.0,Intestinal T-Cell Lymphoma,35.0,Hepatosplenic T-Cell Lymphoma,35.0,Mantle Cell Lymphoma,35.0,"NK-Cell Lymphoma, Unclassifiable",35.0
ANSC,Yes,Anal Carcinoma,20.0,Anal Squamous Cell Carcinoma,20.0,Carcinoma,20.0,Squamous Cell Carcinoma,20.0,Metastatic Anal Squamous Cell Carcinoma,16.0
APAD,Yes,Adenocarcinoma,20.0,Vaginal Adenocarcinoma,10.0,Mesonephric Adenocarcinoma,10.0,Vulvar Adenocarcinoma,10.0,Ovarian Adenocarcinoma,10.0
APL WITH PML-RARA,Yes,Leukemia,20.0,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,17.14,Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,15.0,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,15.0,Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,15.0
ASPS,Yes,Lung Sarcoma,30.0,Lung Alveolar Soft Part Sarcoma,30.0,Lung Soft Tissue Neoplasm,25.0,Lung Kaposi Sarcoma,23.33,Lung Synovial Sarcoma,23.33
ASTROCYTOMA_GRADE_III-IV,Yes,Astrocytoma,60.0,Cervical Carcinoma,20.0,Cervical Squamous Cell Carcinoma,20.0,Carcinoma,20.0,Squamous Cell Carcinoma,20.0
ATL,Yes,Adenocarcinoma,20.0,Metastatic Malignant Neoplasm in the Stomach,15.0,Vaginal Adenocarcinoma,10.0,Mesonephric Adenocarcinoma,10.0,Vulvar Adenocarcinoma,10.0
"ATYPICAL CHRONIC MYELOID LEUKAEMIA, BCR-ABL1 NEGATIVE",No,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",32.14,"Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive",32.14,"Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive",32.14,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",32.14,"Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",32.14
"ATYPICAL CHRONIC MYELOID LEUKEMIA, BCR-ABL1-",No,Atypical Chronic Myeloid Leukemia,75.0,Myeloid Leukemia,65.0,Leukemia,60.0,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",40.0,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",36.43
ATYPICAL LUNG CARCINOID,No,Lung Neuroendocrine Carcinoma,25.0,Combined Lung Carcinoma,25.0,Lung Hilum Carcinoma,25.0,Lung Myoepithelial Carcinoma,25.0,Metastatic Carcinoma in the Lung,25.0
B-CELL_ALL,Yes,Leukemia,35.0,Acute Monocytic Leukemia,35.0,Acute Lymphoblastic Leukemia,35.0,T Acute Lymphoblastic Leukemia,35.0,B Acute Lymphoblastic Leukemia,35.0
BASALOID PENILE SQUAMOUS CELL CARCINOMA,No,Penile Squamous Cell Carcinoma,79.0,Squamous Cell Carcinoma,73.0,Carcinoma,61.0,Penile Basaloid Squamous Cell Carcinoma,45.0,Metastatic Penile Squamous Cell Carcinoma,39.0
BENIGN PT,No,Benign Ameloblastoma,15.0,Benign Meningioma,15.0,Benign Mastocytoma,15.0,Benign Myoepithelioma,15.0,Benign PEComa,15.0
BILIARY TRACT CANCER,No,Biliary Tract Carcinoma,35.0,Metastatic Biliary Tract Carcinoma,30.0,Advanced Biliary Tract Carcinoma,30.0,Unresectable Biliary Tract Carcinoma,30.0,Refractory Biliary Tract Carcinoma,30.0
"BILIARY TRACT CANCER, NOS",No,Biliary Tract Carcinoma,35.0,Metastatic Biliary Tract Carcinoma,30.0,Advanced Biliary Tract Carcinoma,30.0,Unresectable Biliary Tract Carcinoma,30.0,Refractory Biliary Tract Carcinoma,30.0
"BLADDER/URINARY TRACT CANCER, NOS",No,Urinary Tract Carcinoma,30.0,Adenocarcinoma of the Urinary Tract,30.0,Diverticular Carcinoma of the Urinary Tract,30.0,Endometrioid Adenocarcinoma of the Urinary Tract,30.0,Squamous Cell Carcinoma of the Urinary Tract,27.0
BLAST_PHASE_CHRONIC_MYELOID_LEUKAEMIA,Yes,Lymphoid Leukemia,45.0,Recurrent Lymphoid Leukemia,38.33,Aleukemic Lymphoid Leukemia,38.33,Leukemia,35.0,Chronic Leukemia,35.0
BLCA,Yes,Urothelial Carcinoma,35.0,Bladder Urothelial Carcinoma,35.0,Invasive Bladder Urothelial Carcinoma,35.0,Non-Muscle Invasive Bladder Urothelial Carcinoma,35.0,Muscle Invasive Bladder Urothelial Carcinoma,35.0
BLOOD CANCER,Yes,Gastric Carcinoma with Lymphoid Stroma,30.0,Lymphoid Leukemia,30.0,Prostate Carcinoma Metastatic in the Soft Tissue,29.0,Stage I Bladder Cancer with Carcinoma In Situ,25.0,Stage I Bladder Cancer without Carcinoma In Situ,23.33
"BLOOD CANCER, NOS",No,Stage I Bladder Cancer with Carcinoma In Situ,21.0,Stage I Bladder Cancer without Carcinoma In Situ,20.0,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0
BORDERLINE PT,No,Borderline Cystadenoma,15.0,Borderline Serous Cystadenofibroma,10.0,Borderline Papillary Cystadenoma,10.0,Borderline Serous Cystadenoma,10.0,Borderline Phyllodes Tumor,10.0
BRCA,Yes,BRCA-Associated Breast Carcinoma,77.5,Metastatic BRCA-Associated Breast Carcinoma,75.0,BRCA-Associated Ovarian Carcinoma,72.5,Recurrent BRCA- Associated Ovarian Carcinoma,71.0,BRCA-Associated Malignant Neoplasm,57.5
BRCA_LUMA,Yes,Breast Carcinoma,35.0,Breast Lobular Carcinoma,35.0,Invasive Breast Lobular Carcinoma,35.0,Invasive Breast Carcinoma,35.0,Carcinoma,35.0
BRCA_LUMB,Yes,Breast Carcinoma,35.0,Breast Ductal Carcinoma,35.0,Invasive Breast Carcinoma,35.0,Carcinoma,35.0,Invasive Carcinoma,35.0
BRCA_NORMAL,Yes,Breast Carcinoma,35.0,Invasive Breast Carcinoma,35.0,Carcinoma,35.0,Invasive Carcinoma,35.0,Invasive Breast Papillary Carcinoma,30.0
"BREAST INVASIVE CARCINOSARCOMA, NOS",No,Carcinosarcoma,65.0,Sarcoma,55.0,Invasive Sarcomatoid Urothelial Carcinoma,37.5,Invasive Bladder Sarcomatoid Urothelial Carcinoma,36.0,Invasive Renal Pelvis Sarcomatoid Urothelial Carcinoma,35.0
BREAST INVASIVE DUCTAL CARCINOMA,Yes,Carcinoma,82.5,Breast Ductal Carcinoma,57.5,Invasive Breast Carcinoma,57.5,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,55.0,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,55.0
BRONCHIOALVEOLAR_CARCINOMA,Yes,Carcinoma,55.0,Lung Adenocarcinoma,45.0,Lung Non-Small Cell Carcinoma,41.0,Lung Small Cell Carcinoma,40.0,Lung Clear Cell Adenocarcinoma,40.0
BRONCHIOLOALVEOLAR_ADENOCARCINOMA,Yes,Adenocarcinoma,70.0,Carcinoma,55.0,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,50.0,Lung Adenocarcinoma,50.0,Lung Clear Cell Adenocarcinoma,50.0
B_CELL_MEDIASTINAL_LARGE,No,,0.0,,0.0,,0.0,,0.0,,0.0
CANCER IDENTIFICATION IDC,No,Stage I Bladder Cancer with Carcinoma In Situ,21.0,Stage I Bladder Cancer without Carcinoma In Situ,20.0,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0
CANCER IDENTIFICATION MIDLC,No,Stage I Bladder Cancer with Carcinoma In Situ,21.0,Stage I Bladder Cancer without Carcinoma In Situ,20.0,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0
CANCER OF UNKNOWN PRIMARY,Yes,Carcinoma of Unknown Primary,65.0,Adenocarcinoma of Unknown Primary,58.33,Squamous Cell Carcinoma of Unknown Primary,57.0,Neuroendocrine Carcinoma of Unknown Primary,55.0,Resectable Carcinoma of Unknown Primary,55.0
"CANCER OF UNKNOWN PRIMARY, NOS",No,Adenocarcinoma of Unknown Primary,35.0,Carcinoma of Unknown Primary,35.0,Neuroendocrine Carcinoma of Unknown Primary,30.0,Resectable Carcinoma of Unknown Primary,30.0,Resectable Adenocarcinoma of Unknown Primary,30.0
CARCINOID,Yes,Combined Carcinoid and Adenocarcinoma,81.67,Strumal Carcinoid,65.0,Appendix Tubular Carcinoid,60.0,Gallbladder Tubular Carcinoid,60.0,Laryngeal Carcinoid Tumor,60.0
CARCINOID TUMOR,No,Laryngeal Carcinoid Tumor,70.0,Ovarian Teratoma with Carcinoid Tumor,65.0,Ovarian Insular Carcinoid Tumor,65.0,Ovarian Trabecular Carcinoid Tumor,65.0,Ovarian Mucinous Carcinoid Tumor,65.0
CARCINOID-ENDOCRINE TUMOUR,No,Combined Carcinoid and Adenocarcinoma,25.0,Endocrine Mucin-Producing Sweat Gland Carcinoma,20.0,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0
CARCINOMA WITH SQUAMOUS DIFFERENTIATION,No,Invasive Urothelial Carcinoma with Squamous Differentiation,83.0,Invasive Bladder Urothelial Carcinoma with Squamous Differentiation,80.0,Invasive Ureter Urothelial Carcinoma with Squamous Differentiation,80.0,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,77.0,Carcinoma,65.0
CARCINOSARCOMA-MAMMARY GLAND,Yes,Carcinosarcoma,85.0,Sarcoma,55.0,Parotid Gland Carcinosarcoma,48.33,Salivary Gland Carcinosarcoma,48.33,Lacrimal Gland Carcinosarcoma,48.33
CARCINOSARCOMA-MAMMARY GLAND; BREAST,Yes,Carcinosarcoma,82.5,Sarcoma,55.0,Parotid Gland Carcinosarcoma,43.33,Salivary Gland Carcinosarcoma,43.33,Lacrimal Gland Carcinosarcoma,43.33
CCOV,Yes,Ovarian Adenocarcinoma,20.0,Ovarian Clear Cell Adenocarcinoma,20.0,Adenocarcinoma,20.0,Clear Cell Adenocarcinoma,20.0,Advanced Ovarian Clear Cell Adenocarcinoma,16.0
CESC,Yes,Cervical Carcinoma,20.0,Cervical Squamous Cell Carcinoma,20.0,Carcinoma,20.0,Squamous Cell Carcinoma,20.0,Metastatic Cervical Squamous Cell Carcinoma,16.0
CESC_SQUAMOUSCARCINOMA,Yes,Carcinoma,75.0,Cervical Carcinoma,35.0,Cervical Squamous Cell Carcinoma,35.0,Squamous Cell Carcinoma,35.0,Metastatic Cervical Squamous Cell Carcinoma,31.0
CHOL EXTRA,No,Extra-Adrenal Paraganglioma,10.0,Metastatic Extra-Adrenal Paraganglioma,7.5,Extra-Adrenal Sympathetic Paraganglioma,7.5,Extra-Adrenal Retroperitoneal Paraganglioma,7.5,,0.0
CHOLANGIOCARCINOMA; DISTAL,Yes,Cholangiocarcinoma,90.0,Carcinoma,55.0,Advanced Cholangiocarcinoma,40.0,Metastatic Cholangiocarcinoma,40.0,Unresectable Cholangiocarcinoma,40.0
CHRONIC MYELOGENOUS LEUKEMIA,Yes,Leukemia,85.0,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,83.75,Chronic Leukemia,55.0,Lymphoid Leukemia,55.0,Refractory Chronic Leukemia,48.33
CHRONIC MYELOGENOUS LEUKEMIA CML,No,Leukemia,62.5,Cutaneous Chronic Lymphocytic Leukemia,30.0,Refractory Chronic Leukemia,30.0,Refractory Chronic Myelomonocytic Leukemia,30.0,Refractory Chronic Lymphocytic Leukemia,30.0
"CHRONIC MYELOID LEUKEMIA, BCR-ABL1+",No,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",90.0,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",86.43,"Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive",86.43,"Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive",86.43,"Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",86.43
CHRONIC_MYELOID_LEUKAEMIA,Yes,Lymphoid Leukemia,45.0,Recurrent Lymphoid Leukemia,38.33,Aleukemic Lymphoid Leukemia,38.33,Leukemia,35.0,Chronic Leukemia,35.0
CLASSICAL HCA,No,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0,Advanced Urethral Urothelial Carcinoma,15.0,Advanced Bladder Urothelial Carcinoma,15.0
CLEAR CELL PAPILLARY RENAL CELL CARCINOMA,No,Papillary Renal Cell Carcinoma,79.0,Renal Cell Carcinoma,73.0,Carcinoma,61.0,Advanced Papillary Renal Cell Carcinoma,39.0,Advanced Clear Cell Renal Cell Carcinoma,39.0
CML,Yes,Lymphoid Leukemia,45.0,Recurrent Lymphoid Leukemia,38.33,Aleukemic Lymphoid Leukemia,38.33,Leukemia,35.0,Chronic Leukemia,35.0
CNS,Yes,Childhood Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2,60.0,Childhood Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2,60.0,Childhood Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2,60.0,Childhood Acute Lymphoblastic Leukemia CNS-Negative Toronto Guidelines v2,58.75,Childhood Acute Lymphoblastic Leukemia CNS-Positive Toronto Guidelines v2,58.75
CNS CANCER,No,Stage I Bladder Cancer with Carcinoma In Situ,21.0,Stage I Bladder Cancer without Carcinoma In Situ,20.0,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0
COAD,Yes,Colon Adenocarcinoma,20.0,Colorectal Adenocarcinoma,20.0,Adenocarcinoma,20.0,Refractory Colon Adenocarcinoma,13.33,Metastatic Colon Adenocarcinoma,13.33
COAD_GS,Yes,Colon Adenocarcinoma,20.0,Colorectal Adenocarcinoma,20.0,Adenocarcinoma,20.0,Refractory Colon Adenocarcinoma,13.33,Metastatic Colon Adenocarcinoma,13.33
COLON ADENOCARCINOMA IN SITU,No,Colon Adenocarcinoma,90.0,Adenocarcinoma In Situ,90.0,Adenocarcinoma,80.0,Carcinoma In Situ,65.0,Carcinoma,55.0
COLORECTAL HYPERMUTATED,Yes,Colorectal Adenocarcinoma,35.0,Hypermutated Colorectal Carcinoma,33.33,Cecum Adenocarcinoma,30.0,Colorectal Leiomyoma,25.0,Colorectal Lipoma,25.0
CONGENITAL FIBROSARCOMA,No,Fibrosarcoma,70.0,Sarcoma,55.0,Ovarian Fibrosarcoma,30.0,Kidney Fibrosarcoma,30.0,Breast Fibrosarcoma,30.0
COPY-NUMBER HIGH SEROUS-LIKE,No,Ovarian High Grade Serous Adenocarcinoma,12.0,High Grade Burkitt-Like Lymphoma,12.0,Advanced Ovarian High Grade Serous Adenocarcinoma,10.0,Metastatic Ovarian High Grade Serous Adenocarcinoma,10.0,Fallopian Tube High Grade Serous Adenocarcinoma,10.0
COPY-NUMBER LOW ENDOMETRIOD,No,HER2-Low Breast Carcinoma,7.5,Recurrent Low Grade Glioma,7.5,Recurrent Low Grade Astrocytoma,7.5,Childhood Low Grade Glioma,7.5,Low Grade Glioma,7.5
CRC HM,Yes,Cecum Adenocarcinoma,30.0,Cecum Neoplasm,20.0,Cecum Carcinoma,20.0,Cecum Lymphoma,20.0,Colon Adenocarcinoma,20.0
CSCC,Yes,Cutaneous Melanoma,20.0,Skin Carcinoma,20.0,Skin Squamous Cell Carcinoma,20.0,Carcinoma,20.0,Squamous Cell Carcinoma,20.0
CUTANEOUS MALIGNANCY OF HAIR MATRIX CELLS,No,Testicular Teratoma with Somatic-Type Malignancy,6.0,Testicular Seminoma with Syncytiotrophoblastic Cells,6.0,Penile Cutaneous Melanoma,6.0,Ovarian Dermoid Cyst with Somatic-Type Malignancy,6.0,Cutaneous Merkel Cell Carcinoma,6.0
DEDIFFERENTIATED,Yes,Dedifferentiated Liposarcoma,85.0,Dedifferentiated Chordoma,75.0,Dedifferentiated Chondrosarcoma,75.0,Dedifferentiated Leiomyosarcoma,75.0,Unresectable Dedifferentiated Liposarcoma,73.33
DERMATOFIBROMA,No,Fibroma,40.0,,0.0,,0.0,,0.0,,0.0
DUCTAL/NST,Yes,Breast Ductal Carcinoma,30.0,Breast Ductal Adenoma,23.33,Breast Ductal Hyperplasia,23.33,Breast Ductal Carcinoma In Situ,22.5,Metastatic Breast Ductal Carcinoma,22.5
EARLY T-CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA,Yes,Leukemia,81.0,Early T Precursor Lymphoblastic Leukemia/Lymphoma,59.0,Early T Precursor Acute Lymphoblastic Leukemia,55.0,B Lymphoblastic Leukemia/Lymphoma,47.0,T Lymphoblastic Leukemia/Lymphoma,47.0
EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES,Yes,Embryonal Tumor with Multilayered Rosettes,30.0,Stage M0 Embryonal Tumor with Multilayered Rosettes,27.0,Stage M1 Embryonal Tumor with Multilayered Rosettes,27.0,Stage M2 Embryonal Tumor with Multilayered Rosettes,27.0,Stage M3 Embryonal Tumor with Multilayered Rosettes,27.0
EMBT,Yes,Metanephric Tumor,10.0,Krukenberg Tumor,10.0,Wolffian Tumor,10.0,Neuroendocrine Tumor,10.0,Neuroendocrine Tumor G1,10.0
ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE,Yes,Cervical Adenocarcinoma,100.0,Adenocarcinoma,100.0,"Endocervical Adenocarcinoma, Usual-Type",80.0,"Recurrent Endocervical Adenocarcinoma, Usual-Type",67.5,Carcinoma,55.0
EPENDYMOBLASTOMA,Yes,Blastoma,55.0,Vulvar Lipoblastoma-Like Tumor,20.0,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,18.33,Seminal Vesicle Mammary-Type Myofibroblastoma,15.0,Paratesticular Mammary-Type Myofibroblastoma,15.0
EPITHELIOID CELL TUMOR,No,Juxtaglomerular Cell Tumor,20.0,Epithelioid Trophoblastic Tumor,20.0,Leydig Cell Tumor,20.0,Granulosa Cell Tumor,20.0,Sertoli Cell Tumor,20.0
ESCA,Yes,Esophageal Adenocarcinoma,35.0,Adenocarcinoma,35.0,Unresectable Esophageal Adenocarcinoma,28.33,Metastatic Esophageal Adenocarcinoma,28.33,Oligometastatic Esophageal Adenocarcinoma,28.33
ESCA_GS,Yes,Esophageal Adenocarcinoma,35.0,Adenocarcinoma,35.0,Unresectable Esophageal Adenocarcinoma,28.33,Metastatic Esophageal Adenocarcinoma,28.33,Oligometastatic Esophageal Adenocarcinoma,28.33
ESOPHAGUS/STOMACH,Yes,Thoracic Esophagus Squamous Cell Carcinoma,22.0,Cervical Esophagus Squamous Cell Carcinoma,22.0,Distal Esophagus Squamous Cell Carcinoma,22.0,Lung Small Cell Carcinoma,20.0,Esophageal Carcinoma,20.0
ETMR,Yes,Embryonal Tumor with Multilayered Rosettes,15.0,Stage M0 Embryonal Tumor with Multilayered Rosettes,12.0,Stage M1 Embryonal Tumor with Multilayered Rosettes,12.0,Stage M2 Embryonal Tumor with Multilayered Rosettes,12.0,Stage M3 Embryonal Tumor with Multilayered Rosettes,12.0
ETP-ALL,Yes,Leukemia,35.0,B Lymphoblastic Leukemia/Lymphoma,35.0,T Lymphoblastic Leukemia/Lymphoma,35.0,Early T Precursor Lymphoblastic Leukemia/Lymphoma,35.0,B-Cell Leukemia,35.0
EWING-LIKE SARCOMA,No,Sarcoma,65.0,Vulvar Ewing Sarcoma,35.0,Kidney Ewing Sarcoma,35.0,Sinonasal Ewing Sarcoma,35.0,Skin Ewing Sarcoma,35.0
EXTRA-ADRENAL PHEOCHROMOCYTOMA,No,Extra-Adrenal Paraganglioma,20.0,Adrenal Gland Pheochromocytoma,20.0,Childhood Adrenal Gland Pheochromocytoma,15.0,Advanced Adrenal Gland Pheochromocytoma,15.0,Metastatic Extra-Adrenal Paraganglioma,15.0
EXTRAHEPATIC CHOLANGIOCARCINOMA,Yes,Cholangiocarcinoma,90.0,Carcinoma,55.0,Advanced Cholangiocarcinoma,40.0,Metastatic Cholangiocarcinoma,40.0,Unresectable Cholangiocarcinoma,40.0
"FOLLICULAR, PAPILLARY",Yes,Papillary Carcinoma,25.0,Carcinoma,20.0,Thyroid Gland Papillary and Follicular Carcinoma,20.0,Thyroid Gland Papillary Carcinoma,17.5,Thyroid Gland Follicular Carcinoma,17.5
GINET,Yes,Neuroendocrine Tumor,20.0,Neuroendocrine Tumor G1,20.0,Neuroendocrine Tumor G3,20.0,Neuroendocrine Tumor G2,20.0,Metastatic Carcinoma in the Rectum,16.67
"GLIOBLASTOMA, IDH-MUTANT",No,Glioblastoma,65.0,Blastoma,55.0,"Glioblastoma, IDH-Wildtype",35.0,"Recurrent Glioblastoma, IDH-Wildtype",30.0,Recurrent Glioblastoma,25.0
GLIONEURONAL TUMOR,Yes,Rosette-Forming Glioneuronal Tumor,85.0,Myxoid Glioneuronal Tumor,83.33,Papillary Glioneuronal Tumor,83.33,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,80.0,Recurrent Myxoid Glioneuronal Tumor,75.0
GLOMANGIOSARCOMA,No,Angiosarcoma,55.0,Sarcoma,55.0,Metastatic Bladder Sarcomatoid Urothelial Carcinoma,15.0,Metastatic Sarcomatoid Urothelial Carcinoma,15.0,Advanced Sarcomatoid Renal Cell Carcinoma,15.0
HEAD & NECK SQUAMOUS CELL CARCINOMA BASALOID TYPE,Yes,Squamous Cell Carcinoma,90.0,Carcinoma,80.0,Head and Neck Basaloid Squamous Cell Carcinoma,65.0,Head and Neck Squamous Cell Carcinoma,60.0,Recurrent Head and Neck Squamous Cell Carcinoma,56.67
HEAD AND NECK CARCINOMA OTHER,No,Head and Neck Carcinoma,85.0,Neck Carcinoma,75.0,Carcinoma,65.0,Head and Neck Neuroendocrine Carcinoma,37.5,Recurrent Head and Neck Carcinoma,37.5
"HEAD AND NECK CARCINOMA, OTHER",No,Head and Neck Carcinoma,85.0,Neck Carcinoma,75.0,Carcinoma,65.0,Head and Neck Neuroendocrine Carcinoma,37.5,Recurrent Head and Neck Carcinoma,37.5
HEAD AND NECK SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY,Yes,Neck Squamous Cell Carcinoma of Unknown Primary,110.71,Squamous Cell Carcinoma of Unknown Primary,106.43,Carcinoma of Unknown Primary,97.86,Head and Neck Squamous Cell Carcinoma,96.43,Squamous Cell Carcinoma,87.86
HEMANGIOPERICYTOMA OF THE CENTRAL NERVOUS SYSTEM,No,Hemangiopericytoma,47.5,Central Nervous System Paraganglioma,22.5,Central Nervous System Neuroblastoma,22.5,Central Nervous System Ganglioneuroblastoma,22.5,Central Nervous System Leukemia,22.5
HEPATOBILIARY CANCER,Yes,Cholangiocarcinoma,35.0,Intrahepatic Cholangiocarcinoma,35.0,Metastatic Intrahepatic Cholangiocarcinoma,28.33,Advanced Intrahepatic Cholangiocarcinoma,28.33,Oligometastatic Intrahepatic Cholangiocarcinoma,28.33
HEPTOCELLULAR CARCINOMA,No,Carcinoma,70.0,Vaginal Carcinoma,30.0,Vulvar Carcinoma,30.0,Clitoral Carcinoma,30.0,Ovarian Carcinoma,30.0
HGGNOS,Yes,Glioma,20.0,Low Grade Glioma,13.33,WHO Grade 2 Glioma,13.33,WHO Grade 1 Glioma,13.33,WHO Grade 3 Glioma,13.33
HNSC,Yes,Neck Carcinoma,20.0,Head and Neck Carcinoma,20.0,Head and Neck Squamous Cell Carcinoma,20.0,Carcinoma,20.0,Squamous Cell Carcinoma,20.0
HURTHLE,Yes,Carcinoma,20.0,Poorly Differentiated Thyroid Gland Carcinoma,16.0,Differentiated Thyroid Gland Carcinoma,15.0,Poorly Differentiated Hepatocellular Carcinoma,15.0,Oropharyngeal Poorly Differentiated Carcinoma,15.0
HYPOPHARYNGEAL,No,Hypopharyngeal Neoplasm,65.0,Hypopharyngeal Carcinoma,65.0,Benign Hypopharyngeal Neoplasm,60.0,Malignant Hypopharyngeal Neoplasm,60.0,Recurrent Hypopharyngeal Carcinoma,60.0
IDC,Yes,Breast Carcinoma,20.0,Breast Ductal Carcinoma,20.0,Carcinoma,20.0,Breast Ductal Carcinoma In Situ,15.0,Metastatic Breast Ductal Carcinoma,15.0
INFANTILE SARCOMA,No,Sarcoma,70.0,Vaginal Sarcoma,30.0,Ovarian Sarcoma,30.0,Vulvar Sarcoma,30.0,Prostate Sarcoma,30.0
INFILTRATING DUCTAL & LOBULAR,Yes,Breast Mixed Ductal and Lobular Carcinoma,32.0,Breast Lobular Carcinoma,30.0,Breast Ductal Carcinoma,30.0,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,28.0,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,28.0
INFILTRATING DUCTAL CARCINOMA,Yes,Carcinoma,85.0,Breast Ductal Carcinoma,55.0,Breast Ductal Carcinoma In Situ,45.0,Metastatic Breast Ductal Carcinoma,45.0,Breast Carcinoma,45.0
INITIAL CNS TUMOR,Yes,Metanephric Tumor,20.0,Krukenberg Tumor,20.0,Wolffian Tumor,20.0,Neuroendocrine Tumor,20.0,Neuroendocrine Tumor G1,20.0
INITIAL CNS TUMOR FIRST HGG RECORD,No,Ossifying Renal Tumor of Infancy,5.0,Childhood Ovarian Sclerosing Stromal Tumor,5.0,Metanephric Tumor,5.0,Metanephric Stromal Tumor,5.0,Benign Kidney Mixed Epithelial and Stromal Tumor,5.0
INITIAL CNS TUMOR LAST INITIAL,No,Ossifying Renal Tumor of Infancy,7.5,Metanephric Tumor,7.5,Metanephric Stromal Tumor,7.5,Juxtaglomerular Cell Tumor,7.5,Renomedullary Interstitial Cell Tumor,7.5
INITIAL CNS TUMOR NEW LOCATION,No,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor,20.0,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Tumor,20.0,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,19.29,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,19.29,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma,18.75
INVASIVE_DUCTAL_CARCINOMA,Yes,Carcinoma,75.0,Breast Carcinoma,45.0,Breast Ductal Carcinoma,45.0,Invasive Breast Carcinoma,45.0,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,41.0
KICH,Yes,Renal Cell Carcinoma,20.0,Non-Clear Cell Renal Cell Carcinoma,20.0,Chromophobe Renal Cell Carcinoma,20.0,Clear Cell Renal Cell Carcinoma,20.0,Carcinoma,20.0
KIRC,Yes,Renal Cell Carcinoma,20.0,Clear Cell Renal Cell Carcinoma,20.0,Carcinoma,20.0,Advanced Clear Cell Renal Cell Carcinoma,16.0,Metastatic Clear Cell Renal Cell Carcinoma,16.0
KIRP,Yes,Renal Cell Carcinoma,20.0,Non-Clear Cell Renal Cell Carcinoma,20.0,Papillary Renal Cell Carcinoma,20.0,Type 1 Papillary Renal Cell Carcinoma,20.0,Type 2 Papillary Renal Cell Carcinoma,20.0
LAML,Yes,Leukemia,35.0,Myeloid Leukemia,35.0,Acute Myeloid Leukemia,35.0,Acute Myeloid Leukemia with i(17q),35.0,Acute Leukemia,35.0
LGSOC,Yes,Ovarian Adenocarcinoma,20.0,Ovarian Serous Adenocarcinoma,20.0,Ovarian Low Grade Serous Adenocarcinoma,20.0,Adenocarcinoma,20.0,Serous Adenocarcinoma,20.0
LIHB,Yes,Stage I Liver Cancer,23.33,Stage II Liver Cancer,23.33,Stage IV Liver Cancer,23.33,Liver Leiomyoma,20.0,Liver Lipoma,20.0
LIHC,Yes,Hepatocellular Carcinoma,20.0,Carcinoma,20.0,Childhood Hepatocellular Carcinoma,13.33,Metastatic Hepatocellular Carcinoma,13.33,Advanced Hepatocellular Carcinoma,13.33
LIPOFIBROMATOSIS-LIKE NEURAL TUMOR,No,Lipofibromatosis,47.5,Fibroma,40.0,Fibromatosis,40.0,Vulvar Lipoblastoma-Like Tumor,15.0,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,12.0
"LIVER CANCER, NOS",Yes,Liver Carcinoma,50.0,Liver Neuroendocrine Carcinoma,38.33,Metastatic Liver Carcinoma,38.33,Unresectable Liver Carcinoma,38.33,Metastatic Carcinoma in the Liver,38.33
LIVER TUMOR,Yes,Liver Neuroendocrine Tumor G1,43.33,Liver Neuroendocrine Tumor G3,43.33,Liver Neuroendocrine Tumor G2,43.33,Liver Neuroendocrine Tumor,43.33,Liver Solitary Fibrous Tumor,35.0
LIVER_CANCER,No,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0,Advanced Urethral Urothelial Carcinoma,15.0,Advanced Bladder Urothelial Carcinoma,15.0
LNET,Yes,Lung Neuroendocrine Tumor G1,30.0,Lung Neuroendocrine Tumor,30.0,Lung Neuroendocrine Tumor G2,30.0,Non-Functioning Lung Neuroendocrine Tumor,26.0,Lung Non-Small Cell Carcinoma,26.0
LOW HYPODIPLOID,No,Low-Hypodiploid B Acute Lymphoblastic Leukemia,12.0,Low Grade Glioma,10.0,Low Grade Astrocytoma,10.0,Low-CSD Melanoma,10.0,Low Grade Osteosarcoma,10.0
LOW-GRADE NEUROEPITHELIAL TUMOR,No,Polymorphous Low Grade Neuroepithelial Tumor of the Young,20.0,Recurrent Polymorphous Low Grade Neuroepithelial Tumor of the Young,17.14,Recurrent Low Grade Glioma,15.0,Recurrent Low Grade Astrocytoma,15.0,Childhood Low Grade Glioma,15.0
LUAD,Yes,Lung Adenocarcinoma,30.0,Lung Non-Small Cell Carcinoma,26.0,Lung Small Cell Carcinoma,25.0,Lung Clear Cell Adenocarcinoma,25.0,Lung Non-Small Cell Cancer by AJCC v7 Stage,24.29
LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS,Yes,Carcinoma,82.5,Lung Small Cell Carcinoma,50.0,Lung Carcinoma,50.0,Lung Non-Small Cell Carcinoma,47.0,Lung Mucinous Adenocarcinoma In Situ,45.0
LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS,Yes,Carcinoma,82.5,Lung Small Cell Carcinoma,50.0,Lung Carcinoma,50.0,Lung Non-Small Cell Carcinoma,47.0,Lung Spindle Cell Carcinoma,45.0
LUNG CARCINOID,No,Lung Carcinoma,30.0,Lung Adenocarcinoma,30.0,Lung Neuroendocrine Carcinoma,25.0,Combined Lung Carcinoma,25.0,Lung Hilum Carcinoma,25.0
LUNG NEUROENDOCRINE,Yes,Lung Neuroendocrine Tumor G1,100.0,Lung Neuroendocrine Tumor,100.0,Lung Neuroendocrine Tumor G2,100.0,Lung Neuroendocrine Carcinoma,93.33,Lung Neuroendocrine Neoplasm,93.33
LUNG NEUROENDOCRINE TUMOR,Yes,Lung Neuroendocrine Tumor G1,110.0,Lung Neuroendocrine Tumor G2,110.0,Lung Neuroendocrine Tumor,100.0,Advanced Lung Neuroendocrine Tumor,97.5,Metastatic Lung Neuroendocrine Tumor,97.5
LUNG_CARCINOID,No,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0,Advanced Urethral Urothelial Carcinoma,15.0,Advanced Bladder Urothelial Carcinoma,15.0
LUSC,Yes,Lung Small Cell Carcinoma,30.0,Lung Carcinoma,30.0,Lung Non-Small Cell Carcinoma,30.0,Lung Non-Small Cell Squamous Carcinoma,30.0,Lung Non-Squamous Non-Small Cell Carcinoma,30.0
"LYMPHATIC CANCER, NOS",No,Stage I Bladder Cancer with Carcinoma In Situ,21.0,Stage I Bladder Cancer without Carcinoma In Situ,20.0,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0
M0,Yes,Stage M0 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2,50.0,Stage M0 Childhood Medulloblastoma by Toronto Guidelines v2,50.0,Stage M0 Childhood Ependymoma by Toronto Guidelines v2,50.0,Stage M0 Pineoblastoma,50.0,Stage M0 Medulloblastoma,50.0
M2,Yes,Stage M2 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2,50.0,Stage M2 Childhood Medulloblastoma by Toronto Guidelines v2,50.0,Stage M2 Childhood Ependymoma by Toronto Guidelines v2,50.0,Stage M2 Pineoblastoma,50.0,Stage M2 Medulloblastoma,50.0
M3,Yes,Stage M3 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2,50.0,Stage M3 Childhood Medulloblastoma by Toronto Guidelines v2,50.0,Stage M3 Childhood Ependymoma by Toronto Guidelines v2,50.0,Stage M3 Pineoblastoma,50.0,Stage M3 Medulloblastoma,50.0
M4,Yes,Stage M4 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2,50.0,Stage M4 Childhood Medulloblastoma by Toronto Guidelines v2,50.0,Stage M4 Childhood Ependymoma by Toronto Guidelines v2,50.0,Stage M4 Pineoblastoma,50.0,Stage M4 Medulloblastoma,50.0
M5,Yes,Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A,56.67,Leukemia,20.0,Acute Monoblastic and Monocytic Leukemia,20.0,Acute Monocytic Leukemia,20.0,Acute Monoblastic Leukemia,20.0
M6,Yes,Leukemia,20.0,Myeloid Leukemia,20.0,Acute Myeloid Leukemia,20.0,Acute Myeloid Leukemia with i(17q),20.0,Acute Leukemia,20.0
M7,Yes,Leukemia,20.0,Testicular Leukemia,10.0,Meningeal Leukemia,10.0,Leukemia Cutis,10.0,Refractory Leukemia,10.0
MALIGNANT FIBROUS HISTIOCYTOMA,Yes,Fibrous Histiocytoma,80.0,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 2,78.33,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 3,78.33,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 2,77.14,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 3,77.14
MALIGNANT PT,No,Malignant Vipoma,15.0,Malignant Gastrinoma,15.0,Malignant Somatostatinoma,15.0,Malignant Glioma,15.0,Malignant Pericarditis,15.0
MALIGNANT_FIBROUS_HISTIOCYTOMA,No,Histiocytoma,40.0,,0.0,,0.0,,0.0,,0.0
MASKED LOW HYPODIPLOID,No,Low-Hypodiploid B Acute Lymphoblastic Leukemia,12.0,Low Grade Glioma,10.0,Low Grade Astrocytoma,10.0,Low-CSD Melanoma,10.0,Low Grade Osteosarcoma,10.0
MBL,Yes,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,50.0,Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor,50.0,Urothelial Carcinoma,20.0,Bladder Urothelial Carcinoma,20.0,Invasive Bladder Urothelial Carcinoma,20.0
MDS WITH EXCESS BLASTS-2,No,Myelodysplastic Syndrome with Excess Blasts,15.0,Childhood Myelodysplastic Syndrome with Excess Blasts,12.0,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,12.0,Refractory Anemia with Excess Blasts in Transformation,12.0,Myelodysplastic Syndrome with Low Blasts,7.5
MDS WITH ISOLATED DEL5Q,No,Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q,6.0,,0.0,,0.0,,0.0,,0.0
MDS WITH MULTILINEAGE DYSPLASIA,Yes,Acute Myeloid Leukemia with Multilineage Dysplasia,20.0,Fibrous Dysplasia,20.0,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,20.0,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",17.14,Bladder Urothelial Dysplasia,16.67
MDS WITH SINGLE LINEAGE DYSPLASIA,Yes,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",28.33,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,24.29,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",21.25,Fibrous Dysplasia,17.5,Bladder Urothelial Dysplasia,14.17
MDS/MPN WITH RING SIDEROBLASTS AND THROMBOCYTOSIS,Yes,Myelodysplastic Syndrome with Ring Sideroblasts,27.0,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",21.11,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,20.0,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,17.14,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,15.0
"MDS/MPN, UNCLASSIFIABLE",No,"NK-Cell Lymphoma, Unclassifiable",10.0,"Myelodysplastic Syndrome, Unclassifiable",10.0,"Refractory NK-Cell Lymphoma, Unclassifiable",7.5,"Recurrent NK-Cell Lymphoma, Unclassifiable",7.5,Diffuse Large B-Cell Lymphoma Unclassifiable,6.0
MEDULLARY,Yes,Breast Medullary Carcinoma,80.0,Medullary Hemangioblastoma,75.0,Kidney Medullary Carcinoma,73.33,Colon Medullary Carcinoma,73.33,Rectal Medullary Carcinoma,73.33
MED_GROUP_3,Yes,Medulloblastoma,20.0,Metanephric Tumor,10.0,Krukenberg Tumor,10.0,Wolffian Tumor,10.0,Neuroendocrine Tumor,10.0
MENINGOTHELIAL TUMOR,No,Metanephric Tumor,15.0,Krukenberg Tumor,15.0,Wolffian Tumor,15.0,Neuroendocrine Tumor,15.0,Neuroendocrine Tumor G1,15.0
METASTATIC CARCINOMA,No,Metastatic Carcinoma,100.0,Metastatic Carcinoma in the Rectum,85.0,Metastatic Carcinoma in the Pancreas,85.0,Metastatic Carcinoma in the Liver,85.0,Metastatic Carcinoma in the Lung,85.0
METASTATIC HORMONE-SENSITIVE,Yes,Metastatic Prostate Adenocarcinoma,23.33,Prostate Adenocarcinoma,20.0,Adenocarcinoma,20.0,Metastatic Adenocarcinoma,20.0,Metastatic Cervical Adenocarcinoma,16.67
"METASTATIC, VARIANT HISTOLOGY",Yes,Metastatic Prostate Adenocarcinoma,23.33,Prostate Adenocarcinoma,20.0,Adenocarcinoma,20.0,Metastatic Adenocarcinoma,20.0,Metastatic Cervical Adenocarcinoma,16.67
METATYPICAL,No,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0,Advanced Urethral Urothelial Carcinoma,15.0,Advanced Bladder Urothelial Carcinoma,15.0
MICROPAPILLARY ADENOCARCINOMA 82653,No,Adenocarcinoma,85.0,Papillary Adenocarcinoma,85.0,Carcinoma,55.0,Cervical Micropapillary Adenocarcinoma,50.0,Colon Micropapillary Adenocarcinoma,50.0
MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA,No,Renal Cell Carcinoma,70.0,Carcinoma,60.0,Renal Cell Carcinoma with MiT Translocations,35.0,Childhood Renal Cell Carcinoma with MiT Translocations,35.0,Advanced Renal Cell Carcinoma,30.0
MIXED 80% ALVEOLAR,No,Mixed Glioma,15.0,Alveolar Adenoma,15.0,Alveolar Rhabdomyosarcoma,15.0,Mixed Liposarcoma,15.0,Mixed Carcinoma,15.0
MIXED ACINAR-NEUROENDOCRINE CARCINOMA,No,Neuroendocrine Carcinoma,70.0,Carcinoma,62.5,Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma,39.0,Pancreatic Mixed Acinar-Ductal Carcinoma,33.0,Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma,32.14
"MIXED PHENOTYPE ACUTE LEUKAEMIA, T/MYELOID, NOS",No,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",39.0,"Mixed Phenotype Acute Leukemia, B/Myeloid",39.0,"Mixed Phenotype Acute Leukemia, T/Myeloid",39.0,Refractory Mixed Phenotype Acute Leukemia,33.0,Recurrent Mixed Phenotype Acute Leukemia,33.0
"MIXED PHENOTYPE ACUTE LEUKEMIA, B/MYELOID, NOS",No,"Mixed Phenotype Acute Leukemia, B/Myeloid",85.0,Mixed Phenotype Acute Leukemia,79.0,Acute Leukemia,67.0,Leukemia,61.0,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",45.0
"MIXED PHENOTYPE ACUTE LEUKEMIA, T/MYELOID, NOS",No,"Mixed Phenotype Acute Leukemia, T/Myeloid",85.0,Mixed Phenotype Acute Leukemia,79.0,Acute Leukemia,67.0,Leukemia,61.0,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",45.0
MIXED SEROUS AND ENDOMETRIOID,No,Paratesticular Serous Cystadenoma,10.0,Ovarian Endometrioid Adenofibroma,10.0,Ovarian Endometrioid Cystadenofibroma,10.0,Ovarian Endometrioid Cystadenoma,10.0,Ovarian Serous Cystadenoma,10.0
"MLL TRANSLOCATION, T9;11",No,Metastatic Genitourinary System Carcinoma,15.0,Metastatic Urothelial Carcinoma,15.0,Advanced Urothelial Carcinoma,15.0,Advanced Urethral Urothelial Carcinoma,15.0,Advanced Bladder Urothelial Carcinoma,15.0
MLL-ALL,Yes,Leukemia,35.0,Acute Leukemia,35.0,Acute Leukemia of Ambiguous Lineage,35.0,Refractory Acute Leukemia of Ambiguous Lineage,31.0,Recurrent Acute Leukemia of Ambiguous Lineage,31.0
MMMT,Yes,Uterine Carcinosarcoma,20.0,Carcinosarcoma,20.0,Malignant Mixed Mesodermal (Mullerian) Tumor,16.0,Mixed Mesodermal (Mullerian) Tumor,15.0,Malignant Mixed Tumor of the Skin,15.0
MULTIPLE MYELOMA,Yes,Multiple Myeloma,100.0,Refractory Multiple Myeloma,85.0,Recurrent Multiple Myeloma,85.0,Multiple Myeloma Myeloma by DS Stage,85.0,DS Stage I Multiple Myeloma,85.0
MULTIPLE_MYELOMA,Yes,Multiple Myeloma,35.0,Refractory Multiple Myeloma,28.33,Recurrent Multiple Myeloma,28.33,Multiple Myeloma Myeloma by DS Stage,28.33,DS Stage I Multiple Myeloma,28.33
MUSCLE INVASIVE UROTHELIAL CARCINOMA PT2 OR ABOVE,No,Invasive Urothelial Carcinoma,70.0,Urothelial Carcinoma,65.0,Carcinoma,60.0,Recurrent Muscle Invasive Bladder Urothelial Carcinoma,35.0,Non-Muscle Invasive Bladder Urothelial Carcinoma,35.0
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL5Q,No,Myelodysplastic Syndrome,52.0,SAMD9-Associated Hereditary Myelodysplastic Syndrome,18.0,SAMD9L-Associated Hereditary Myelodysplastic Syndrome,18.0,Refractory Myelodysplastic Syndrome,12.0,Recurrent Myelodysplastic Syndrome,12.0
"MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE",No,Myelodysplastic/Myeloproliferative Neoplasm,62.5,Myeloproliferative Neoplasm,55.0,Refractory Myelodysplastic/Myeloproliferative Neoplasm,22.5,Recurrent Myelodysplastic/Myeloproliferative Neoplasm,22.5,Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q,18.0
MYELOMA,Yes,Multiple Myeloma,80.0,Refractory Multiple Myeloma,75.0,Recurrent Multiple Myeloma,75.0,Multiple Myeloma Myeloma by DS Stage,75.0,DS Stage I Multiple Myeloma,75.0
NESTED STROMAL EPITHELIAL TUMOR OF THE LIVER,No,Calcifying Nested Stromal-Epithelial Tumor,24.0,Kidney Mixed Epithelial and Stromal Tumor,18.0,Benign Kidney Mixed Epithelial and Stromal Tumor,15.0,Malignant Mixed Epithelial and Stromal Tumor of the Kidney,15.0,Seminal Vesicle Mixed Epithelial and Stromal Tumor,15.0
NEUROTROPIC,No,Desmoplastic Neurotropic Melanoma,60.0,,0.0,,0.0,,0.0,,0.0
NKC,Yes,Leukemia,20.0,B Lymphoblastic Lymphoma,20.0,B Lymphoblastic Leukemia/Lymphoma,20.0,T Lymphoblastic Lymphoma,20.0,T Lymphoblastic Leukemia/Lymphoma,20.0
NON AML MDSMPN DIAGNOSIS AT ACQUISITION,No,Adult Non-T Non-B Acute Lymphoblastic Leukemia,21.0,Childhood Non-T Non-B Acute Lymphoblastic Leukemia,21.0,"Monoclonal B-Cell Lymphocytosis, Non-Chronic Lymphocytic Leukemia Type",19.29,Non-T Non-B CALLA Negative Adult Acute Lymphoblastic Leukemia,19.29,Non-T Non-B CALLA Positive Adult Acute Lymphoblastic Leukemia,19.29
NON-SEMINOMA,Yes,Intratubular Non-Seminoma,83.33,Seminoma,75.0,Testicular Non-Seminomatous Germ Cell Tumor,71.67,Malignant Testicular Non-Seminomatous Germ Cell Tumor,68.57,Childhood Testicular Non-Seminomatous Germ Cell Tumor,68.57
NORMAL-LIKE,Yes,Breast Carcinoma,20.0,Normal Breast-Like Subtype of Breast Carcinoma,20.0,Invasive Breast Carcinoma,20.0,Carcinoma,20.0,Invasive Carcinoma,20.0
NO_FUSION,No,,0.0,,0.0,,0.0,,0.0,,0.0
NSCLC,Yes,Lung Non-Small Cell Carcinoma,26.0,Lung Small Cell Carcinoma,25.0,Lung Non-Small Cell Cancer by AJCC v7 Stage,24.29,Stage IV Lung Non-Small Cell Cancer AJCC v7,24.29,Stage I Lung Non-Small Cell Cancer AJCC v7,24.29
OV,Yes,Ovarian Carcinoma,60.0,Metastatic Ovarian Carcinoma,56.67,Advanced Ovarian Carcinoma,56.67,Refractory Ovarian Carcinoma,56.67,Unresectable Ovarian Carcinoma,56.67
PAAD,Yes,Pancreatic Adenocarcinoma,20.0,Adenocarcinoma,20.0,Metastatic Carcinoma in the Pancreas,16.67,Benign Exocrine Pancreas Neoplasm,15.0,Malignant Exocrine Pancreas Neoplasm,15.0
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND,Yes,Carcinoma,80.0,Breast Papillary Ductal Carcinoma In Situ,46.0,Breast Papillary Carcinoma,45.0,Invasive Breast Papillary Carcinoma,45.0,Breast Ductal Carcinoma,45.0
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND; BREAST,Yes,Carcinoma,79.29,Breast Papillary Ductal Carcinoma In Situ,48.14,Breast Papillary Carcinoma,47.86,Invasive Breast Papillary Carcinoma,47.86,Breast Ductal Carcinoma,47.86
"PAPILLARY, FOLLICULAR",Yes,Papillary Carcinoma,25.0,Carcinoma,20.0,Thyroid Gland Papillary and Follicular Carcinoma,20.0,Thyroid Gland Papillary Carcinoma,17.5,Thyroid Gland Follicular Carcinoma,17.5
PAST,Yes,Medulloblastoma,20.0,Metanephric Tumor,10.0,Krukenberg Tumor,10.0,Wolffian Tumor,10.0,Neuroendocrine Tumor,10.0
PDA - MIXED DUCTAL ENDOCRINE CARCINOMA,Yes,Carcinoma,81.0,Pancreatic Mixed Acinar-Ductal Carcinoma,49.0,Mixed Carcinoma,47.0,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,46.67,Breast Mixed Ductal and Lobular Carcinoma,45.0
PDA - MUCINOUS NON-CYSTIC CARCINOMA,Yes,Carcinoma,81.0,Pancreatic Carcinoma,41.0,Mucinous Adenocarcinoma,41.0,Breast Mucinous Carcinoma,40.33,Adenoid Cystic Carcinoma,40.33
PDA - UNDIFFERENTIATED CARCINOMA SOME MULTINUCLEATED BUT NOT OSTEOCLAST,No,Undifferentiated Carcinoma,62.5,Carcinoma,58.75,Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,26.25,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,26.25,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,26.25
PENILE SQUAMOUS CELL CARCINOMA,Yes,Metastatic Penile Squamous Cell Carcinoma,105.0,Unresectable Penile Squamous Cell Carcinoma,105.0,"Penile Squamous Cell Carcinoma, Usual Type",105.0,Penile Squamous Cell Carcinoma,100.0,Locally Advanced Penile Squamous Cell Carcinoma,98.33
PERITONEAL MESOTHELIOMA,No,Peritoneal Malignant Mesothelioma,20.0,Peritoneal Sarcomatoid Mesothelioma,20.0,Peritoneal Biphasic Mesothelioma,20.0,Peritoneal Epithelioid Mesothelioma,20.0,Peritoneal Multicystic Mesothelioma,20.0
PERITONEAL SEROUS CARCINOMA,No,Carcinoma,65.0,Primary Peritoneal Carcinoma,35.0,Micropapillary Serous Carcinoma,35.0,Serous Tubal Intraepithelial Carcinoma,30.0,Serous Endometrial Intraepithelial Carcinoma,30.0
PERIVASCULAR EPITHELIOID CELL TUMOR,No,Epithelioid Cell Type Gastrointestinal Stromal Tumor,18.0,Juxtaglomerular Cell Tumor,15.0,Renomedullary Interstitial Cell Tumor,15.0,Benign Sertoli Cell Tumor,15.0,Juvenile Granulosa Cell Tumor,15.0
PFA,Yes,"Posterior Fossa Ependymoma, Group A (PFA)",60.0,Glioma,20.0,Ependymoma,20.0,Recurrent Glioma,10.0,Recurrent Ependymoma,10.0
PH+-ALL,No,Testicular Leukemia,15.0,Meningeal Leukemia,15.0,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",15.0,Central Nervous System Leukemia,15.0,Cutaneous Adult T-Cell Leukemia/Lymphoma,15.0
PH-LIKEALL,No,Testicular Leukemia,15.0,Meningeal Leukemia,15.0,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",15.0,Central Nervous System Leukemia,15.0,Cutaneous Adult T-Cell Leukemia/Lymphoma,15.0
PITUITARY ADENOMA,No,Adenoma,55.0,Metanephric Adenoma,15.0,Kidney Adenoma,15.0,Prostate Adenoma,15.0,Vaginal Adenoma,15.0
PLASMA CELL MYELOMA,No,Plasma Cell Myeloma-Induced Bone Disease,80.0,Refractory Multiple Myeloma,25.0,Recurrent Multiple Myeloma,25.0,Multiple Myeloma,25.0,Multiple Myeloma Myeloma by DS Stage,25.0
PLASMA_CELL_MYELOMA,No,Extramedullary Disease in Multiple Myeloma Involving the Kidney,15.0,Extramedullary Disease in Multiple Myeloma Involving the Uterine Corpus,15.0,Extramedullary Disease in Multiple Myeloma Involving the Liver,15.0,Extramedullary Disease in Multiple Myeloma Involving the Central Nervous System,15.0,Extramedullary Disease in Multiple Myeloma Involving the Leptomeninges,15.0
PLEURAL MESOTHELIOMA,Yes,Pleural Mesothelioma In Situ,83.33,Pleural Malignant Mesothelioma,33.33,Pleural Epithelioid Mesothelioma,33.33,Pleural Sarcomatoid Mesothelioma,33.33,Pleural Desmoplastic Mesothelioma,33.33
PLMESO,Yes,Metastatic Malignant Neoplasm in the Pleura,15.0,Pleural Malignant Mesothelioma,13.33,Pleural Epithelioid Mesothelioma,13.33,Pleural Sarcomatoid Mesothelioma,13.33,Pleural Desmoplastic Mesothelioma,13.33
PNET,Yes,Primitive Neuroectodermal Tumor,20.0,Recurrent Primitive Neuroectodermal Tumor,15.0,Peripheral Primitive Neuroectodermal Tumor,15.0,Refractory Primitive Neuroectodermal Tumor,15.0,Localized Primitive Neuroectodermal Tumor,15.0
POORLY DIFFERENTIATED OR PLEOMORPHIC OR EPITHELIOID LEIOMYOSARCOMA,No,Epithelioid Leiomyosarcoma,67.0,Leiomyosarcoma,61.0,Sarcoma,55.0,Uterine Corpus Epithelioid Leiomyosarcoma,27.0,Poorly Differentiated Angiosarcoma,27.0
PRAD,Yes,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma,50.0,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma,50.0,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,50.0,Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,50.0,Ann Arbor Stage II Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma,50.0
PRE-T,Yes,Breast Carcinoma,20.0,Breast Ductal Carcinoma,20.0,Invasive Breast Carcinoma,20.0,Carcinoma,20.0,Invasive Carcinoma,20.0
PRIMARY CNS MELANOMA,No,Melanoma,65.0,Melanoma of Unknown Primary,35.0,Bladder Melanoma,25.0,Urethral Melanoma,25.0,Penile Mucosal Melanoma,25.0
PRIMARY MEDIASTINAL THYMIC DLBCL,No,Mediastinal/Thymic NUT Carcinoma,15.0,Primary Mediastinal Large B-Cell Lymphoma,12.0,Childhood Primary Mediastinal Large B-Cell Lymphoma,10.0,Recurrent Primary Mediastinal Large B-Cell Lymphoma,10.0,Refractory Primary Mediastinal Large B-Cell Lymphoma,10.0
PRIMARY MEDIASTINAL THYMIC LARGE B-CELL LYMPHOMA,No,Lymphoma,60.0,Childhood Primary Mediastinal Large B-Cell Lymphoma,40.0,Recurrent Primary Mediastinal Large B-Cell Lymphoma,40.0,Refractory Primary Mediastinal Large B-Cell Lymphoma,40.0,Primary Mediastinal Large B-Cell Lymphoma,40.0
PRIMARY RESIDUAL,No,Primary Amyloidosis,15.0,Primary Myelofibrosis,15.0,Primary Neoplasm,15.0,Primary Peritoneal Carcinosarcoma,10.0,Primary Breast Angiosarcoma,10.0
PRO MYELOCYTIC LEUKEMIA,No,Leukemia,65.0,Testicular Leukemia,25.0,Meningeal Leukemia,25.0,Leukemia Cutis,25.0,Aleukemic Leukemia Cutis,25.0
RAEB,Yes,Myelodysplastic Syndrome with Excess Blasts,15.0,Childhood Myelodysplastic Syndrome with Excess Blasts,12.0,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,12.0,Myelodysplastic Syndrome,10.0,Myelodysplastic Syndrome with Low Blasts,10.0
RARS,Yes,Myelodysplastic Syndrome with Ring Sideroblasts,15.0,Myelodysplastic/Myeloproliferative Neoplasm,13.33,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",11.11,Refractory Myelodysplastic/Myeloproliferative Neoplasm,10.0,Recurrent Myelodysplastic/Myeloproliferative Neoplasm,10.0
RARS-T,Yes,Myelodysplastic Syndrome with Ring Sideroblasts,15.0,Myelodysplastic/Myeloproliferative Neoplasm,13.33,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",11.11,Refractory Myelodysplastic/Myeloproliferative Neoplasm,10.0,Recurrent Myelodysplastic/Myeloproliferative Neoplasm,10.0
RCMD,Yes,Myelodysplastic Syndrome,10.0,Fibrous Dysplasia,10.0,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,10.0,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",8.57,Acute Myeloid Leukemia with Multilineage Dysplasia,8.0
READ,Yes,Medulloblastoma with Leptomeningeal Spread,50.0,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",50.0,"Low-CSD Melanoma, Superficial Spreading Melanoma Subtype",50.0,Superficial Spreading Adenocarcinoma,50.0,Urothelial Carcinoma,20.0
READ_GS,Yes,Rectal Adenocarcinoma,20.0,Colorectal Adenocarcinoma,20.0,Adenocarcinoma,20.0,Metastatic Rectal Adenocarcinoma,13.33,Advanced Rectal Adenocarcinoma,13.33
RECURRENCE FIRST HGG RECORD,No,,0.0,,0.0,,0.0,,0.0,,0.0
REFRACTORY ANEMIA WITH EXCESS BLASTS-2,No,Refractory Anemia,55.0,Refractory Anemia with Excess Blasts in Transformation,24.0,Myelodysplastic Syndrome with Excess Blasts,15.0,Childhood Myelodysplastic Syndrome with Excess Blasts,12.0,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,12.0
REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,No,Refractory Cytopenia of Childhood,15.0,Acute Myeloid Leukemia with Multilineage Dysplasia,12.0,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,10.0,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,10.0,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",8.57
REL CELL CARCINOMA,No,Carcinoma,65.0,Renal Cell Carcinoma,35.0,Merkel Cell Carcinoma,35.0,Basal Cell Carcinoma,35.0,Granular Cell Carcinoma,35.0
RENAL SPINDLE CELL CARCINOMA,No,Carcinoma,62.5,Advanced Renal Cell Carcinoma,37.5,Metastatic Renal Cell Carcinoma,37.5,Refractory Renal Cell Carcinoma,37.5,Recurrent Renal Cell Carcinoma,37.5
ROSAI-DORFMAN DISEASE,No,Rosai-Dorfman-Destombes Disease,22.5,Cutaneous Rosai-Dorfman-Destombes Disease,18.0,Bone Rosai-Dorfman-Destombes Disease,18.0,Thyroid Gland Rosai-Dorfman-Destombes Disease,15.0,Head and Neck Rosai-Dorfman-Destombes Disease,15.0
"ROUND CELL SARCOMA, OTHER",No,Sarcoma,65.0,Undifferentiated Round Cell Sarcoma,37.5,Mast Cell Sarcoma,35.0,Langerhans Cell Sarcoma,35.0,Spindle Cell Sarcoma,35.0
RT,Yes,Warty Carcinoma,60.0,Vaginal Warty Carcinoma,56.67,Vulvar Warty Carcinoma,56.67,Bartholin Gland Carcinoma,56.67,Cervical Warty Carcinoma,56.67
SARC LMS,Yes,Leiomyosarcoma,20.0,Sarcoma,20.0,Sarcoma GX,20.0,Sarcoma G2,20.0,Sarcoma G3,20.0
SARC LS,Yes,Soft Tissue Sarcoma,20.0,Liposarcoma,20.0,Dedifferentiated Liposarcoma,20.0,Sarcoma,20.0,Sarcoma GX,20.0
SARCOMA LEIOMYO,Yes,Sarcoma,90.0,Sarcoma GX,50.0,Sarcoma G2,50.0,Sarcoma G3,50.0,Sarcoma G1,50.0
SARC_DDLPS,Yes,Liposarcoma,20.0,Dedifferentiated Liposarcoma,20.0,Sarcoma,20.0,Sarcoma GX,20.0,Sarcoma G2,20.0
SARC_LMS,Yes,Leiomyosarcoma,20.0,Sarcoma,20.0,Sarcoma GX,20.0,Sarcoma G2,20.0,Sarcoma G3,20.0
SARC_OTHER,No,,0.0,,0.0,,0.0,,0.0,,0.0
SBS,Yes,Small Intestinal Cancer by AJCC v7 Stage,8.0,Stage IV Small Intestinal Cancer AJCC v7,8.0,Stage 0 Small Intestinal Cancer AJCC v7,8.0,Stage I Small Intestinal Cancer AJCC v7,8.0,Stage II Small Intestinal Cancer AJCC v7,8.0
SCCOHT,Yes,Ovarian Carcinoma,20.0,Ovarian Small Cell Carcinoma,20.0,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",20.0,Carcinoma,20.0,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",16.67
SCHMINKE TUMOR/LYMPHOEPITHELIAL CARCINOMA,Yes,Carcinoma,82.5,Laryngeal Lymphoepithelial Carcinoma,43.33,Sinonasal Lymphoepithelial Carcinoma,43.33,Lung Lymphoepithelial Carcinoma,43.33,Skin Lymphoepithelial Carcinoma,43.33
"SEROUS BORDERLINE OVARIAN TUMOR, MICROPAPILLARY",No,Borderline Ovarian Serous Tumor,24.0,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,20.0,Borderline Ovarian Serous Papillary Cystic Tumor,20.0,Borderline Ovarian Serous Surface Papillary Tumor,20.0,Benign Ovarian Serous Tumor,18.0
SEROUS_CARCINOMA,Yes,Carcinoma,55.0,Ovarian Clear Cell Cystadenocarcinoma,35.0,Ovarian Cystadenocarcinoma,35.0,Cystadenocarcinoma,35.0,Ovarian Clear Cell Adenocarcinoma,30.0
SKCM,Yes,Metastatic Melanoma in the Skin,23.33,Skin Neoplasm,20.0,Skin Lymphangioleiomyomatosis,20.0,Skin Glomangioma,20.0,Skin Leiomyoma,20.0
SMALL CELL CARCINOMA OF UNKNOWN PRIMARY,No,Carcinoma of Unknown Primary,73.0,Carcinoma,61.0,Squamous Cell Carcinoma of Unknown Primary,39.0,Neck Squamous Cell Carcinoma of Unknown Primary,35.0,Vaginal Small Cell Neuroendocrine Carcinoma,33.0
SMOLDERING MYELOMA,No,Smoldering Multiple Myeloma,35.0,Multiple Myeloma,30.0,Refractory Multiple Myeloma,25.0,Recurrent Multiple Myeloma,25.0,Multiple Myeloma Myeloma by DS Stage,25.0
SOFT TISSUE MYOEPITHELIAL CARCINOMA,No,Carcinoma,62.5,Prostate Carcinoma Metastatic in the Soft Tissue,33.0,Soft Palate Carcinoma,30.0,Salivary Gland Myoepithelial Carcinoma,30.0,Lacrimal Gland Myoepithelial Carcinoma,30.0
SOLID ADENOCARCINOMA 82303,No,Adenocarcinoma,85.0,Carcinoma,55.0,Solid Lung Adenocarcinoma,50.0,Vaginal Adenocarcinoma,45.0,Mesonephric Adenocarcinoma,45.0
SPECIFIC DX AT ACQUISITION MDSMPN,No,No Specific Molecular Profile Endometrial Endometrioid Adenocarcinoma,5.0,Patient-Specific Neoantigen-Positive Malignant Solid Neoplasm,4.29,,0.0,,0.0,,0.0
SPECIFIC_DX_AT_ACQUISITION_MDSMPN,Yes,Leukemia,20.0,Myeloid Leukemia,20.0,Acute Myeloid Leukemia,20.0,Acute Myeloid Leukemia with i(17q),20.0,Acute Leukemia,20.0
ST-RELPOS,No,,0.0,,0.0,,0.0,,0.0,,0.0
ST-YAP,No,,0.0,,0.0,,0.0,,0.0,,0.0
STAD,Yes,Seminal Vesicle Cystadenoma,50.0,Paratesticular Serous Cystadenoma,50.0,Paratesticular Mucinous Cystadenoma,50.0,Epididymal Cystadenoma,50.0,Epididymal Papillary Cystadenoma,50.0
STAD_GS,Yes,Adenocarcinoma,20.0,Vaginal Adenocarcinoma,10.0,Mesonephric Adenocarcinoma,10.0,Vulvar Adenocarcinoma,10.0,Ovarian Adenocarcinoma,10.0
SUPERFICIAL SPREADING,Yes,Superficial Spreading Adenocarcinoma,83.33,"Low-CSD Melanoma, Superficial Spreading Melanoma Subtype",70.0,Superficial Angiomyxoma,25.0,Superficial Fibromatosis,25.0,Cutaneous Melanoma,20.0
SUPERFICIAL SPREADING MELANOMA,Yes,"Low-CSD Melanoma, Superficial Spreading Melanoma Subtype",90.0,Melanoma,85.0,Bladder Melanoma,35.0,Urethral Melanoma,35.0,Vaginal Melanoma,35.0
SWEAT GLAND ADENOCARCINOMA,No,Adenocarcinoma,80.0,Carcinoma,55.0,Bartholin Gland Adenocarcinoma,50.0,Thyroid Gland Adenocarcinoma,50.0,Parotid Gland Adenocarcinoma,50.0
S_T_MDS,No,,0.0,,0.0,,0.0,,0.0,,0.0
"T-CELL, NON-HODGKINS, CUTANEOUS",No,Cutaneous Merkel Cell Carcinoma,15.0,Cutaneous Granular Cell Tumor,15.0,Cutaneous Mantle Cell Lymphoma,15.0,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,15.0,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma,15.0
"T-CELL, NON-HODGKINS, CUTANEOUS, SEZARY SYNDROME",No,Sezary Syndrome,50.0,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,15.0,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma,15.0,Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma,15.0,Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma,15.0
T-CELL_ALL,Yes,Leukemia,35.0,Acute Lymphoblastic Leukemia,35.0,T Acute Lymphoblastic Leukemia,35.0,B Acute Lymphoblastic Leukemia,35.0,Acute Leukemia,35.0
TALL,Yes,Breast Tall Cell Carcinoma with Reversed Polarity,58.33,Tall Cell Variant Thyroid Gland Papillary Carcinoma,57.14,Leukemia,35.0,Lymphoid Leukemia,35.0,Acute Leukemia,35.0
TC:SCC,Yes,Ovarian Epithelial Tumor,13.33,Thymic Neuroendocrine Tumor,13.33,Thymic Neuroendocrine Tumor G2,13.33,Thymic Neuroendocrine Tumor G1,13.33,Thymic Epithelial Neoplasm,13.33
TGCT SEM,Yes,Testicular Seminoma,20.0,Testicular Germ Cell Tumor,20.0,Germ Cell Tumor,20.0,Seminoma,20.0,Rete Testis Adenoma,16.67
THCA,Yes,Urothelial Carcinoma,35.0,Bladder Urothelial Carcinoma,35.0,Invasive Bladder Urothelial Carcinoma,35.0,Non-Muscle Invasive Bladder Urothelial Carcinoma,35.0,Muscle Invasive Bladder Urothelial Carcinoma,35.0
THERAPY-RELATED MYELODYSPLASTIC SYNDROME,No,Myelodysplastic Syndrome,55.0,Epipodophyllotoxin-Related Myelodysplastic Syndrome,22.5,Myelodysplastic Syndrome Post Cytotoxic Therapy,18.0,Alkylating Agent-Related Myelodysplastic Syndrome,18.0,Refractory Myelodysplastic Syndrome,15.0
THERAPY-RELATED MYELOID NEOPLASMS,Yes,Myeloid Neoplasm,57.5,Therapy-Related Leukemia,35.0,Therapy-Related Neoplasm,28.33,Myeloid Leukemia,27.5,Endometrioid Stromal and Related Neoplasms,25.0
THPA,Yes,Thyroid Gland Papillary Carcinoma,25.0,Thyroid Gland Carcinoma,23.33,Childhood Thyroid Gland Papillary Carcinoma,22.0,Recurrent Thyroid Gland Papillary Carcinoma,22.0,Refractory Thyroid Gland Papillary Carcinoma,22.0
THPD,Yes,Poorly Differentiated Thyroid Gland Carcinoma,22.0,Recurrent Poorly Differentiated Thyroid Gland Carcinoma,20.0,Metastatic Poorly Differentiated Thyroid Gland Carcinoma,20.0,Unresectable Poorly Differentiated Thyroid Gland Carcinoma,20.0,Differentiated Thyroid Gland Carcinoma,20.0
THYMOMA; TYPE C,No,Thymoma,70.0,Thymoma Type B3,30.0,Thymoma Type A,30.0,Thymoma Type AB,30.0,Thymoma Type B,30.0
TRANSLOCATION-ASSOCIATED RENAL CELL CARCINOMA,No,Renal Cell Carcinoma,73.0,Carcinoma,61.0,Renal Cell Carcinoma Associated with Neuroblastoma,39.0,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),35.0,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),35.0
TYPE A,Yes,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",62.0,"Mixed Phenotype Acute Leukemia, B/Myeloid",62.0,"Mixed Phenotype Acute Leukemia, T/Myeloid",62.0,Mixed Phenotype Acute Leukemia,60.0,"Mixed Phenotype Acute Leukemia, B/T",60.0
TYPE ATHYMOMA,No,Thymoma,40.0,,0.0,,0.0,,0.0,,0.0
TYPE C,No,Type C Lymphomatoid Papulosis,50.0,,0.0,,0.0,,0.0,,0.0
T_CELL_ALCL,No,,0.0,,0.0,,0.0,,0.0,,0.0
UCEC ENDO,Yes,Endometrial Carcinoma,20.0,Carcinoma,20.0,Metastatic Endometrial Carcinoma,13.33,Advanced Endometrial Carcinoma,13.33,Endometrial Adenosquamous Carcinoma,13.33
UCS,Yes,Uterine Carcinosarcoma,60.0,"Uterine Carcinosarcoma, Homologous Type",53.33,"Uterine Carcinosarcoma, Heterologous Type",53.33,Uterine Corpus Carcinosarcoma,33.33,Advanced Uterine Corpus Carcinosarcoma,30.0
UM,Yes,Medium/Large Size Posterior Uveal Melanoma,90.0,Cecum Carcinoma,60.0,Luminal A Prostate Carcinoma,56.67,Luminal B Prostate Carcinoma,56.67,Penile Carcinoma Cuniculatum,56.67
UNCLASSIFIED RENAL CELL CARCINOMA,Yes,Renal Cell Carcinoma,97.5,Carcinoma,82.5,Advanced Renal Cell Carcinoma,52.5,Metastatic Renal Cell Carcinoma,52.5,Refractory Renal Cell Carcinoma,52.5
UNKNOWN TUMOR,No,Metanephric Tumor,15.0,Krukenberg Tumor,15.0,Wolffian Tumor,15.0,Neuroendocrine Tumor,15.0,Neuroendocrine Tumor G1,15.0
URACHAL ADENOCARCINOMA,Yes,Adenocarcinoma,105.0,Urachal Adenocarcinoma,100.0,Bladder Adenocarcinoma,65.0,Vaginal Adenocarcinoma,55.0,Mesonephric Adenocarcinoma,55.0
URACHAL CARCINOMA,No,Urachal Carcinoma,100.0,Carcinoma,70.0,Urachal Urothelial Carcinoma,35.0,Metastatic Urachal Urothelial Carcinoma,30.0,Vaginal Carcinoma,30.0
UTERINE PERIVASCULAR EPITHELIOID CELL TUMOR,No,Uterine Corpus Germ Cell Tumor,18.0,Epithelioid Cell Type Gastrointestinal Stromal Tumor,18.0,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,15.0,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,15.0,Juxtaglomerular Cell Tumor,12.0
UVM,Yes,Uveal Melanoma,60.0,Metastatic Uveal Melanoma,53.33,Advanced Uveal Melanoma,53.33,Unresectable Uveal Melanoma,53.33,Refractory Uveal Melanoma,53.33
